Allergy Relief — Class II drug recall D-0902-2023
Terminated recall by L. Perrigo Company, reported 2023-07-19, distributed nationwide. Failed Impurities/Degradation Specifications
| Recall number | D-0902-2023 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | L. Perrigo Company, Allegan, MI, United States |
| Recall initiated | 2023-02-09 |
| Classified | 2023-07-11 |
| Reported by FDA | 2023-07-19 |
| Terminated | 2023-09-11 |
| Distributed | Nationwide (US) |
| Quantity | 3,240 cartons |
| Reason classes | specification failure |
| NDC | 72476-0847, 72476-0847-22, 72476-0847-39, 72476-0847-95 |
| Lot numbers | 01/24, 2JE2185 |
Product
Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg, 15-count cartons, Distributed By: Adusa Distribution, LLC, Salisbury, NC 28147. NDC 72476-847-22
Reason for recall
Failed Impurities/Degradation Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0902-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.